Skip to main content

IFN-alpha G/IFNA5 Antibody (08)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-30740

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

ELISA

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # 08

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human IFN-alpha G/IFNA5 (Uniprot#: P01569; Met1-Glu189)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Applications for IFN-alpha G/IFNA5 Antibody (08)

Application
Recommended Usage

ELISA

1:1000-1:2000

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

0.2 um filtered solution in PBS

Preservative

No Preservative

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: IFN-alpha G/IFNA5

Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of twoenzymes: a protein kinase and an oligoadenylate synthetase

Long Name

Interferon alpha G

Alternate Names

Ifa5, IFNA5, IFNalpha G

Gene Symbol

IFNA5

UniProt

Additional IFN-alpha G/IFNA5 Products

Product Documents for IFN-alpha G/IFNA5 Antibody (08)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for IFN-alpha G/IFNA5 Antibody (08)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...